|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2002-9-12
|
|
pubmed:abstractText |
Identification of leukemia-associated antigens (LAA) eliciting an immune response in patients is a prerequisite for specific immunotherapy of leukemias. To identify new LAA, we used the method of serologic screening of cDNA expression libraries (SEREX).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD44,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Matrix Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/hyaluronan-mediated motility...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0301-472X
|
|
pubmed:author |
pubmed-author:BergmannLotharL,
pubmed-author:DöhnerHartmutH,
pubmed-author:GreinerJochenJ,
pubmed-author:GschwendJürgenJ,
pubmed-author:HeilmannVolkerV,
pubmed-author:KirchnerDieterD,
pubmed-author:KrähnGertraudG,
pubmed-author:RinghofferMarkM,
pubmed-author:SchmittAnitaA,
pubmed-author:SchmittMichaelM,
pubmed-author:TaniguchiMasanoriM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1029-35
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12225794-Acute Disease,
pubmed-meshheading:12225794-Antibodies, Neoplasm,
pubmed-meshheading:12225794-Antibody Specificity,
pubmed-meshheading:12225794-Antigens, CD44,
pubmed-meshheading:12225794-Antigens, Neoplasm,
pubmed-meshheading:12225794-Breast Neoplasms,
pubmed-meshheading:12225794-Carcinoma,
pubmed-meshheading:12225794-Computer Systems,
pubmed-meshheading:12225794-Extracellular Matrix Proteins,
pubmed-meshheading:12225794-Female,
pubmed-meshheading:12225794-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:12225794-Humans,
pubmed-meshheading:12225794-K562 Cells,
pubmed-meshheading:12225794-Kidney Neoplasms,
pubmed-meshheading:12225794-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:12225794-Leukemia, Myeloid,
pubmed-meshheading:12225794-Male,
pubmed-meshheading:12225794-Melanoma,
pubmed-meshheading:12225794-Monocytes,
pubmed-meshheading:12225794-Neoplasm Metastasis,
pubmed-meshheading:12225794-Neoplasm Proteins,
pubmed-meshheading:12225794-Neoplasms,
pubmed-meshheading:12225794-Neoplastic Stem Cells,
pubmed-meshheading:12225794-Organ Specificity,
pubmed-meshheading:12225794-Ovarian Neoplasms,
pubmed-meshheading:12225794-RNA, Messenger,
pubmed-meshheading:12225794-RNA, Neoplasm,
pubmed-meshheading:12225794-Reverse Transcriptase Polymerase Chain Reaction
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
|
|
pubmed:affiliation |
Third Department of Internal Medicine, University of Ulm, Ulm, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
